Laura F. Ogle

Framlington Place
Newcastle Upon Tyne, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Identification of TIAM1 as a Potential Synthetic-Lethal-like Gene in a Defined Subset of Hepatocellular Carcinoma.

Identification of TIAM1 as a Potential Synthetic-Lethal-like Gene in a Defined Subset of Hepatocellular Carcinoma.

Journal: International journal of molecular sciences

Published: January 31, 2023

Neurosteroid Activation of GABA-A Receptors: A Potential Treatment Target for Symptoms in Primary Biliary Cholangitis?

Neurosteroid Activation of GABA-A Receptors: A Potential Treatment Target for Symptoms in Primary Biliary Cholangitis?

Journal: Canadian journal of gastroenterology & hepatology

Published: June 13, 2022

The relationship between disease activity and UDCA response criteria in primary biliary cholangitis: A cohort study.

The relationship between disease activity and UDCA response criteria in primary biliary cholangitis: A cohort study.

Journal: EBioMedicine

Published: November 23, 2021

The Serum Proteome and Ursodeoxycholic Acid Response in Primary Biliary Cholangitis.

The Serum Proteome and Ursodeoxycholic Acid Response in Primary Biliary Cholangitis.

Journal: Hepatology (Baltimore, Md.)

Published: January 08, 2021

Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?

Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?

Journal: British journal of cancer

Published: July 01, 2017

Sulfatase-2: a prognostic biomarker and candidate therapeutic target in patients with pancreatic ductal adenocarcinoma.

Sulfatase-2: a prognostic biomarker and candidate therapeutic target in patients with pancreatic ductal adenocarcinoma.

Journal: British journal of cancer

Published: July 13, 2016

Imagestream detection and characterisation of circulating tumour cells - A liquid biopsy for hepatocellular carcinoma?

Imagestream detection and characterisation of circulating tumour cells - A liquid biopsy for hepatocellular carcinoma?

Journal: Journal of hepatology

Published: October 20, 2015

DNA-PK-A candidate driver of hepatocarcinogenesis and tissue biomarker that predicts response to treatment and survival.

DNA-PK-A candidate driver of hepatocarcinogenesis and tissue biomarker that predicts response to treatment and survival.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: December 07, 2014

High-resolution imaging for the detection and characterisation of circulating tumour cells from patients with oesophageal, hepatocellular, thyroid and ovarian cancers.

High-resolution imaging for the detection and characterisation of circulating tumour cells from patients with oesophageal, hepatocellular, thyroid and ovarian cancers.

Journal: International journal of cancer

Published: October 09, 2014

Showing 1-9 of 9

Last Updated: 09/26/2026